This inventor holds 1 USPTO granted patent. Top assignee: Teijin Limited. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Hiroshi Saitou: Innovator in Benzimidazole Derivatives
Introduction
Hiroshi Saitou is a notable inventor based in Hino, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on benzimidazole derivatives. His innovative approach has led to advancements in the development of human chymase activity inhibitors.
Latest Patents
Hiroshi Saitou holds a patent for a benzimidazole derivative or its medically acceptable salt. This compound is represented by a specific formula and is recognized for its potential clinical applications. The patent details a human chymase activity inhibitor that can be utilized in medical treatments.
Career Highlights
Saitou is associated with Teijin Limited, a company known for its commitment to innovation and research in various fields. His work at Teijin Limited has allowed him to explore and develop new pharmaceutical compounds that can have a significant impact on healthcare.
Collaborations
Throughout his career, Hiroshi Saitou has collaborated with esteemed colleagues such as Naoki Tsuchiya and Yoshiyuki Matsumoto. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Hiroshi Saitou's contributions to the field of medicinal chemistry, particularly through his patent on benzimidazole derivatives, highlight his role as an innovator. His work continues to influence the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile